Detecting breast cancer early is vital for effective treatment. New research looks at tiny structures called extracellular vesicles, or EVs. These are small bubbles released by cells that carry proteins on their surface. Scientists found that these EV-derived proteins have a high ability to distinguish between healthy tissue and cancerous cells.
The study looked at how well these markers performed as diagnostic tools. The results showed a strong capacity for identification, but researchers warn we must be careful with the data. Because there were only a few studies available and they used many different methods, the findings are not yet ready for everyday use in clinics.
While these protein markers show great potential, several hurdles remain. There is currently no standard way to measure them across different labs, and doctors do not have specific thresholds to decide when a test is positive. More large-scale testing is needed before this can become a standard tool for patients.
